evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract,articles/12/pmid,articles/12/title,articles/12/journal,articles/12/pubDate,articles/12/volume,articles/12/issue,articles/12/pages,articles/12/authors,articles/12/elocationId,articles/12/link,articles/12/reference,articles/12/abstract,articles/13/pmid,articles/13/title,articles/13/journal,articles/13/pubDate,articles/13/volume,articles/13/issue,articles/13/pages,articles/13/authors,articles/13/elocationId,articles/13/link,articles/13/reference,articles/13/abstract,articles/14/pmid,articles/14/title,articles/14/journal,articles/14/pubDate,articles/14/volume,articles/14/issue,articles/14/pages,articles/14/authors,articles/14/elocationId,articles/14/link,articles/14/reference,articles/14/abstract,articles/15/pmid,articles/15/title,articles/15/journal,articles/15/pubDate,articles/15/volume,articles/15/issue,articles/15/pages,articles/15/authors,articles/15/elocationId,articles/15/link,articles/15/reference,articles/15/abstract,articles/16/pmid,articles/16/title,articles/16/journal,articles/16/pubDate,articles/16/volume,articles/16/issue,articles/16/pages,articles/16/authors,articles/16/elocationId,articles/16/link,articles/16/reference,articles/16/abstract,articles/17/pmid,articles/17/title,articles/17/journal,articles/17/pubDate,articles/17/volume,articles/17/issue,articles/17/pages,articles/17/authors,articles/17/elocationId,articles/17/link,articles/17/reference,articles/17/abstract,articles/18/pmid,articles/18/title,articles/18/journal,articles/18/pubDate,articles/18/volume,articles/18/issue,articles/18/pages,articles/18/authors,articles/18/elocationId,articles/18/link,articles/18/reference,articles/18/abstract
19738,GENE_BACKGROUND,,"CDKN2C encodes for cyclin-dependent kinase inhibitor 2C. It binds to and inhibits cyclin dependent kinases (CDK) to prevent cell cycle progression at the G1 phase (PMID:11124804). Its regulation of cell division is important for B-cell, muscle, and cerebellar development (PMID: 21163929, 9528803,16864777). Expression is suppressed in cancer cells to promote cell cycle progression and induce proliferation (PMID: 22997239, 19411068, 17409423). Deletions and mutations are found in multiple cancer types including myeloma, lymphoma, glioblastoma, meningioma, melanoma, thyroid, and parathyroid cancer (PMID:25576899,16960149, 23616356, 22133722,18829482, 18381405, 11485924 ). Its has also been associated with poorer prognosis in certain cancer types (PMID: 21994415, 20303590, 15349907,19455257). Mutations or loss of expression activate cyclin dependent kinases (CDK) and thus subject these tumors to greater sensitivity to CDK inhibitors (PMID:22711607).CDKN2C encodes for cyclin-dependent kinase inhibitor 2C. It binds to and inhibits cyclin dependent kinase (CDK) activity to prevent cell cycle progression. Its regulation of cell division is important for B-cell development (PMID: 21163929). Expression is suppressed in cancer cells to promote cell cycle progression and prevent proliferation (PMID: 22997239, 19411068). Mutations are found in multiple cancer types including melenoma, thyroid, parathyroid cancer (PMID:25576899, 23616356, 22133722). Mutations or loss of expression may activated cyclin dependent kinases (CDK) and thus subject these tumors to greater sensitivity to CDK inhibitors (PMID:22711607).",,2017-05-22,,1031,CDKN2C,cyclin dependent kinase inhibitor 2C,False,ENST00000262662,NM_078626.2,p18-INK4C,p18,INK4C,True,16864777,N-Myc and the cyclin-dependent kinase inhibitors p18Ink4c and p27Kip1 coordinately regulate cerebellar development.,Proceedings of the National Academy of Sciences of the United States of America,2018-08-01T20:06:00,103,31,11579-83,Zindy F et al,,,0001-08-01,,21994415,Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival.,Clinical cancer research : an official journal of the American Association for Cancer Research,2017-12-15T20:11:00,17,24,7776-84,Boyd KD et al,doi: 10.1158/1078-0432.CCR-11-1791,,0001-12-15,,17409423,p18Ink4c collaborates with Men1 to constrain lung stem cell expansion and suppress non-small-cell lung cancers.,Cancer research,2018-04-01T20:07:00,67,7,3162-70,Pei XH et al,,,0001-04-01,,19411068,CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis.,Cancer cell,2018-05-05T20:09:00,15,5,389-401,Pei XH et al,doi: 10.1016/j.ccr.2009.03.004,,2018-05-05T04:01:00,,21163929,Noxa mediates p18INK4c cell-cycle control of homeostasis in B cells and plasma cell precursors.,Blood,2018-02-17T20:11:00,117,7,2179-88,Bretz J et al,doi: 10.1182/blood-2010-06-288027,,0001-02-17,,11124804,Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors.,Genes &amp; development,2017-12-15T20:00:00,14,24,3115-25,Jeffrey PD et al,,,0001-12-15,,9528803,Coupled transcriptional and translational control of cyclin-dependent kinase inhibitor p18INK4c expression during myogenesis.,Molecular and cellular biology,0001-04-01,18,4,2334-43,Phelps DE et al,,,0001-04-01,,16960149,Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas.,Blood,2018-01-01T20:07:00,109,True,271-80,Mestre-Escorihuela C et al,,,0001-01-01,,18381405,Identification of p18 INK4c as a tumor suppressor gene in glioblastoma multiforme.,Cancer research,2018-04-15T20:08:00,68,8,2564-9,Solomon DA et al,doi: 10.1158/0008-5472.CAN-07-6388,,0001-04-15,,20303590,Prognostic classification of patients with acute lymphoblastic leukemia by using gene copy number profiles identified from array-based comparative genomic hybridization data.,Leukemia research,2018-11-01T20:10:00,34,11,1476-82,Usvasalo A et al,doi: 10.1016/j.leukres.2010.02.031,,0001-11-01,,19455257,"Germinal center B cell-like (GCB) and activated B cell-like (ABC) type of diffuse large B cell lymphoma (DLBCL): analysis of molecular predictors, signatures, cell cycle state and patient survival.",Cancer informatics,2017-12-12T20:07:00,3,,399-420,Blenk S et al,,,2017-12-12T04:20:00,,15349907,Reduced expression of cell cycle regulator p18(INK4C) in human hepatocellular carcinoma.,"Hepatology (Baltimore, Md.)",2018-09-01T20:04:00,40,3,677-86,Morishita A et al,,,0001-09-01,,22997239,Dual suppression of the cyclin-dependent kinase inhibitors CDKN2C and CDKN1A in human melanoma.,Journal of the National Cancer Institute,2018-11-07T20:12:00,104,21,1673-9,Jalili A et al,doi: 10.1093/jnci/djs373,,0001-11-07,,23616356,Complete genomic landscape of a recurring sporadic parathyroid carcinoma.,The Journal of pathology,2018-07-01T20:13:00,230,3,249-60,Kasaian K et al,doi: 10.1002/path.4203,,0001-07-01,,25576899,Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.,Human molecular genetics,2018-04-15T20:15:00,24,8,2318-29,Kunstman JW et al,doi: 10.1093/hmg/ddu749,,0001-04-15,,18829482,Deletions of CDKN2C in multiple myeloma: biological and clinical implications.,Clinical cancer research : an official journal of the American Association for Cancer Research,2018-10-01T20:08:00,14,19,6033-41,Leone PE et al,doi: 10.1158/1078-0432.CCR-08-0347,,0001-10-01,,11485924,"Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.",The American journal of pathology,2018-08-01T20:01:00,159,2,661-9,Boström J et al,,,0001-08-01,,22133722,Personalized oncology through integrative high-throughput sequencing: a pilot study.,Science translational medicine,2017-11-30T20:11:00,3,111,111ra121,Roychowdhury S et al,doi: 10.1126/scitranslmed.3003161,,2017-11-30T01:11:00,,22711607,p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells.,Neuro-oncology,2018-07-01T20:12:00,14,7,870-81,Cen L et al,doi: 10.1093/neuonc/nos114,,0001-07-01,
19737,GENE_SUMMARY,,"CDKN2C encodes for a cyclin dependent kinase inhibitor. It is deleted or mutated in various cancer types including lymphoma, CNS neoplasms, and thyroid cancers.",,2017-04-19,,1031,CDKN2C,cyclin dependent kinase inhibitor 2C,False,ENST00000262662,NM_078626.2,p18-INK4C,p18,INK4C,True,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
